Comments
Loading...
Renovaro (RENB) Forecast
NewsEarningsRenovaro (RENB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Renovaro Stock Price, Quotes and Forecasts | NASDAQ:RENB | Benzinga
Explore Renovaro stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RENB.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Renovaro (RENB) stock?
You can purchase shares of Renovaro (NASDAQ:RENB) through any online brokerage.
Who are Renovaro (RENB) competitors?
Other companies in Renovaro’s space includes: Serina Therapeutics (AMEX:SER), Kalaris Therapeutics (NASDAQ:KLRS), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX) and bluebird bio (NASDAQ:BLUE).
What is the forecast, or price target, for Renovaro (RENB) stock?
There is no analysis for Renovaro to provide a consensus price target.
What is the current price for Renovaro (RENB)?
The stock price for Renovaro (NASDAQ: RENB) is $0.3098 last updated May 29, 2025 at 3:26 PM EDT.
Does Renovaro (RENB) pay a dividend?
There are no upcoming dividends for Renovaro.
When is Renovaro (NASDAQ:RENB) reporting earnings?
Renovaro’s Q3 earnings are confirmed for Thursday, May 15, 2025.
Is Renovaro (RENB) going to split?
There is no upcoming split for Renovaro.
What sector and industry does Renovaro (RENB) operate in?
Renovaro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
